Department of Clinical Laboratory, 1st Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.
J Ethnopharmacol. 2011 Sep 2;137(2):985-91. doi: 10.1016/j.jep.2011.07.018. Epub 2011 Jul 18.
Diabetes mellitus is frequently combined with vascular diseases, which are associated with the expression of vascular endothelial growth factor (VEGF). An approach that can reverse the induction of VEGF by hyperglycemia may potentially benefit the outcome of diabetic patients. Therefore, in the present study, we investigated the effect of Salvia miltiorrhiza (S. miltiorrhiza) hydrophilic extract on the expression of VEGF induced by high concentration of glucose.
Vector of VEGF promoter luc was transiently transfected into HMEC-1 cells, and luciferase activity was measured to determine the promoter activity. In order to investigate the mechanism of Salvia miltiorrhiza hydrophilic extract, mitochondrial uncoupling protein 2(UCP2) was knockdown by using UCP2 siRNA. The expression of VEGF was obtained by using quantitative RT-PCR and dot blot. The level of reactive oxygen species (ROS) was expressed by the level of 2',7'-dichlorfluorescein.
Exposure of HMEC-1 cells to 30 mM glucose resulted in a significant increase in the expression of VEGF mRNA (5.7 fold at 3mM glucose, P<0.005), and an increase of ROS formation (2.4 fold at 3mM glucose, P<0.005). These effects were completely antagonized by an inhibitor of electron transport chain complex II, thenoyltrifluoroacetone (TTFA) and an uncoupler of oxidative phosphorylation, carbonylcyanide-m-chlorophenylhydrazone (CCCP). Addition of Salvia miltiorrhiza hydrophilic extract (10 μg/ml) led to a significant decrease of VEGF mRNA and ROS formation in 30 mM glucose condition. Interestingly, knockdown of mitochondrial UCP-2 by UCP-2 siRNA abolished the reduction of VEGF expression and ROS formation by Salvia miltiorrhiza hydrophilic extract.
These findings indicated that Salvia miltiorrhiza hydrophilic extract effectively reversed induction of VEGF expression by high glucose via ameliorating mitochondrial oxidative stress. Salvia miltiorrhiza hydrophilic extract can potentially be an effective antioxidant therapy for the treatment of diabetic chronic vascular complication.
糖尿病常伴有血管疾病,其与血管内皮生长因子(VEGF)的表达有关。一种可以逆转高血糖诱导 VEGF 表达的方法可能对糖尿病患者的预后有益。因此,本研究旨在探讨丹参水溶性提取物对高浓度葡萄糖诱导的 VEGF 表达的影响。
将 VEGF 启动子 luc 载体瞬时转染到 HMEC-1 细胞中,通过测量荧光素酶活性来确定启动子活性。为了研究丹参水溶性提取物的作用机制,采用 UCP2 siRNA 敲低线粒体解偶联蛋白 2(UCP2)。通过定量 RT-PCR 和斑点印迹法检测 VEGF 的表达。通过 2',7'-二氯荧光素的水平来表示活性氧(ROS)的水平。
暴露于 30mM 葡萄糖的 HMEC-1 细胞导致 VEGF mRNA 的表达显著增加(3mM 葡萄糖时增加 5.7 倍,P<0.005),并增加 ROS 形成(3mM 葡萄糖时增加 2.4 倍,P<0.005)。这些作用完全被电子传递链复合物 II 的抑制剂三氟乙酸(TTFA)和氧化磷酸化的解偶联剂羰基氰化物 m-氯苯腙(CCCP)拮抗。添加丹参水溶性提取物(10μg/ml)可显著降低 30mM 葡萄糖条件下的 VEGF mRNA 和 ROS 形成。有趣的是,UCP-2 siRNA 敲低线粒体 UCP-2 可消除丹参水溶性提取物对 VEGF 表达和 ROS 形成的降低作用。
这些发现表明,丹参水溶性提取物通过改善线粒体氧化应激,有效逆转高糖诱导的 VEGF 表达。丹参水溶性提取物可能是治疗糖尿病慢性血管并发症的有效抗氧化治疗方法。